First Time Loading...

Ortho Clinical Diagnostics Holdings PLC
NASDAQ:OCDX

Watchlist Manager
Ortho Clinical Diagnostics Holdings PLC Logo
Ortho Clinical Diagnostics Holdings PLC
NASDAQ:OCDX
Watchlist
Price: 17.63 USD 0.46% Market Closed
Updated: May 13, 2024

Ortho Clinical Diagnostics Holdings PLC
Research & Development

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Ortho Clinical Diagnostics Holdings PLC
Research & Development Peer Comparison

Comparables:
BDX
BSX
SYK
ABT
ISRG

Competitive Research & Development Analysis
Latest Figures & CAGR of Competitors

Company Research & Development CAGR 3Y CAGR 5Y CAGR 10Y
Ortho Clinical Diagnostics Holdings PLC
NASDAQ:OCDX
Research & Development
-$126.2m
CAGR 3-Years
-9%
CAGR 5-Years
-5%
CAGR 10-Years
N/A
Becton Dickinson and Co
NYSE:BDX
Research & Development
-$1.2B
CAGR 3-Years
-5%
CAGR 5-Years
-3%
CAGR 10-Years
-9%
Boston Scientific Corp
NYSE:BSX
Research & Development
-$1.4B
CAGR 3-Years
-9%
CAGR 5-Years
-5%
CAGR 10-Years
-5%
Stryker Corp
NYSE:SYK
Research & Development
-$1.3B
CAGR 3-Years
-10%
CAGR 5-Years
-9%
CAGR 10-Years
-9%
Abbott Laboratories
NYSE:ABT
Research & Development
-$2.6B
CAGR 3-Years
-2%
CAGR 5-Years
-2%
CAGR 10-Years
-7%
Intuitive Surgical Inc
NASDAQ:ISRG
Research & Development
-$1B
CAGR 3-Years
-20%
CAGR 5-Years
-17%
CAGR 10-Years
-20%

See Also

What is Ortho Clinical Diagnostics Holdings PLC's Research & Development?
Research & Development
-126.2m USD

Based on the financial report for Jan 2, 2022, Ortho Clinical Diagnostics Holdings PLC's Research & Development amounts to -126.2m USD.

What is Ortho Clinical Diagnostics Holdings PLC's Research & Development growth rate?
Research & Development CAGR 5Y
-5%

Over the last year, the Research & Development growth was -12%. The average annual Research & Development growth rates for Ortho Clinical Diagnostics Holdings PLC have been -9% over the past three years , -5% over the past five years .